ArticleThe Lancet. Infectious diseases2022
The global impact of disproportionate vaccination coverage on COVID-19 mortality.
Article in The Lancet. Infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Predictors of COVID-19 vaccination status among youth in eThekwini, South Africa: results from the AYAZAZI RIGHTS study.Global health action · 2026Article
- Mortality risk during the COVID-19 pandemic is shaped by human development.BMC global and public health · 2026Article
- Vaccination Against SARS-CoV-2 and its Outcomes on Incidence, Lethality and Mortality from COVID-19 in the City of São Paulo, Brazil.International journal of preventive medicine · 2026Article
- Oral delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical intestinal disease.Science translational medicine · 2025Article
- Blood Banking Capacity in Low-and Middle-Income Countries: Covid-19 Convalescent Plasma in Context.Current topics in microbiology and immunology · 2025Review
- A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines.Nature biotechnology · 2024Article
- How manufacturing won or lost the COVID-19 vaccine race.Vaccine · 2024Review
- Article
- Sustaining Functionality of Not-for-Profit Health Organisations During Pandemics: Lessons and COVID 19 Experience from Makerere University Walter Reed Project.The East African health research journal · 2024Article
- COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated.Vaccines · 2023Article
- General approach to delivery and resuscitation of newborn infants from mothers at risk or proven COVID-19.Seminars in fetal & neonatal medicine · 2023Review
- Review
- The influence of share buybacks on ill-health and health inequity: an exploratory analysis using a socio-ecological determinants of health lens.Globalization and health · 2023Article
- Real-world effectiveness of COVID-19 vaccines among Colombian adults: A retrospective, population-based study of the ESPERANZA cohort.PLOS global public health · 2023Article
- Ethical implications for children's exclusion in the initial COVID-19 vaccination in Ghana.Global bioethics = Problemi di bioetica · 2023Article
- Development and initial validation of the attitudes toward face mask use scale (ATFMUS).Heliyon · 2022Article
- COVID-19 pandemic: Current & future perspectives.The Indian journal of medical researchArticle
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.